Distinct functional and molecular profiles between physiological and pathological atrial enlargement offer potential new therapeutic opportunities for atrial fibrillation

Yi Ching Chen,Seka Wijekoon,Aya Matsumoto,Jieting Luo,Helen Kiriazis,Emma Masterman,Gunes Yildiz,Jonathon Cross,Adam Parslow,Roger Chooi,Junichi Sadoshima,David Greening,Kate Weeks,Julie R McMullen
DOI: https://doi.org/10.1042/cs20240178
2024-07-18
Clinical Science
Abstract:Atrial fibrillation (AF) remains challenging to prevent and treat. A key feature of AF is atrial enlargement. However, not all atrial enlargement progresses to AF. Atrial enlargement in response to physiological stimuli such as exercise is typically benign and reversible. Understanding the differences in atrial function and molecular profile underpinning pathological and physiological atrial remodelling will be critical for identifying new strategies for AF. The discovery of molecular mechanisms...
medicine, research & experimental
What problem does this paper attempt to address?